Hogan DJ. Sebaceous hyperplasia of the chest. Int J Dermatol. 1991 Apr. 30(4):306. [QxMD MEDLINE Link].
Krisp A, Krause W. Areolar sebaceous hyperplasia. Acta Derm Venereol. 2003. 83(1):61-2. [QxMD MEDLINE Link].
Daley TD. Intraoral sebaceous hyperplasia. Diagnostic criteria. Oral Surg Oral Med Oral Pathol. 1993 Mar. 75(3):343-7. [QxMD MEDLINE Link].
Ma HJ, Zhao G, Wang YX. Sebaceous hyperplasia of the scrotum in an adolescent boy. Pediatr Dermatol. 2007 May-Jun. 24(3):340-2. [QxMD MEDLINE Link].
Ena P, Origa D, Massarelli G. Sebaceous gland hyperplasia of the foreskin. Clin Exp Dermatol. 2009 Apr. 34(3):372-4. [QxMD MEDLINE Link].
Ju HY, Kim HS, Kim HO, Park YM. Sebaceous hyperplasia of the penile shaft. J Eur Acad Dermatol Venereol. 2009 Apr. 23(4):443-4. [QxMD MEDLINE Link].
Bakaris S, Kiran H, Kiran G. Sebaceous gland hyperplasia of the vulva. Aust N Z J Obstet Gynaecol. 2004 Feb. 44(1):75-6. [QxMD MEDLINE Link].
Malliah R, Gilhooly P, Lambert WC, Heller DS. Sebaceous hyperplasia of the vulva: case report and review of the literature. J Low Genit Tract Dis. 2006 Jan. 10(1):55-7. [QxMD MEDLINE Link].
Rocamora A, Santonja C, Vives R, Varona C. Sebaceous gland hyperplasia of the vulva: a case report. Obstet Gynecol. 1986 Sep. 68(3 Suppl):63S-65S. [QxMD MEDLINE Link].
Kato N, Yasuoka A. "Giant" senile sebaceous hyperplasia. J Dermatol. 1992 Apr. 19(4):238-41. [QxMD MEDLINE Link].
Sato T, Tanaka M. Linear sebaceous hyperplasia on the chest. Dermatol Pract Concept. 2014 Jan. 4 (1):93-5. [QxMD MEDLINE Link].
Mandal RK, Das A, Chakrabarti I, Agarwal P. Nevoid sebaceous hyperplasia mistaken as nevus sebaceous: Report of four cases. Indian J Dermatol Venereol Leprol. 2017 Mar-Apr. 83 (2):213-216. [QxMD MEDLINE Link].
Marini M, Saponaro A, Remorino L, Lynch P, Magarinos G. Eruptive lesions in a patient with bone marrow transplantation. Int J Dermatol. 2001 Feb. 40(2):133-5. [QxMD MEDLINE Link].
Salim A, Reece SM, Smith AG, et al. Sebaceous hyperplasia and skin cancer in patients undergoing renal transplant. J Am Acad Dermatol. 2006 Nov. 55(5):878-81. [QxMD MEDLINE Link].
de Berker DA, Taylor AE, Quinn AG, Simpson NB. Sebaceous hyperplasia in organ transplant recipients: shared aspects of hyperplastic and dysplastic processes?. J Am Acad Dermatol. 1996 Nov. 35(5 Pt 1):696-9. [QxMD MEDLINE Link].
Dupre A, Bonafe JL, Lamon P. Functional familial sebaceous hyperplasia of the face and premature sebaceous gland hyperplasia: a new and unique entity. J Am Acad Dermatol. 1983 Nov. 9(5):768-9. [QxMD MEDLINE Link].
Grimalt R, Ferrando J, Mascaro JM. Premature familial sebaceous hyperplasia: successful response to oral isotretinoin in three patients. J Am Acad Dermatol. 1997 Dec. 37(6):996-8. [QxMD MEDLINE Link].
Wang Q, Liu JM, Zhang YZ. Premature sebaceous hyperplasia in an adolescent boy. Pediatr Dermatol. 2011 Mar-Apr. 28(2):198-200. [QxMD MEDLINE Link].
Wilken R, Fung MA, Shi VY, Cheng MY, Patel F, Sultani H, et al. Cyclosporine-induced sebaceous hyperplasia in a hematopoetic stem cell transplant patient: delayed onset of a common adverse event. Dermatol Online J. 2016 Jan 15. 22 (1):[QxMD MEDLINE Link].
Levandoski KA, Girardi NA, Loss MJ. Eruptive sebaceous hyperplasia as a side effect of oral tacrolimus in a renal transplant recipient. Dermatol Online J. 2017 May 15. 23 (5):[QxMD MEDLINE Link].
Boschnakow A, May T, Assaf C, Tebbe B, Zouboulis ChC. Ciclosporin A-induced sebaceous gland hyperplasia. Br J Dermatol. 2003 Jul. 149(1):198-200. [QxMD MEDLINE Link].
Engel F, Ellero B, Woehl-Jaegle ML, Cribier B. [Diffuse sebaceous hyperplasia of the face induced by cyclosporine]. Ann Dermatol Venereol. 2005 Apr. 132(4):342-5. [QxMD MEDLINE Link].
McDonald SK, Goh MS, Chong AH. Successful treatment of cyclosporine-induced sebaceous hyperplasia with oral isotretinoin in two renal transplant recipients. Australas J Dermatol. 2011 Aug. 52(3):227-30. [QxMD MEDLINE Link].
Kanada KN, Merin MR, Munden A, Friedlander SF. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr. 2012 Aug. 161(2):240-5. [QxMD MEDLINE Link].
Moosavi Z, Hosseini T. One-year survey of cutaneous lesions in 1000 consecutive Iranian newborns. Pediatr Dermatol. 2006 Jan-Feb. 23(1):61-3. [QxMD MEDLINE Link].
Johnson PJ, Heckler F. Muir-Torre syndrome. Ann Plast Surg. 1998 Jun. 40(6):676-7. [QxMD MEDLINE Link].
Finan MC, Apgar JT. Juxta-clavicular beaded lines: a subepidermal proliferation of sebaceous gland elements. J Cutan Pathol. 1991 Dec. 18(6):464-8. [QxMD MEDLINE Link].
Argenziano G, Zalaudek I, Corona R, et al. Vascular structures in skin tumors: a dermoscopy study. Arch Dermatol. 2004 Dec. 140(12):1485-9. [QxMD MEDLINE Link].
Bryden AM, Dawe RS, Fleming C. Dermatoscopic features of benign sebaceous proliferation. Clin Exp Dermatol. 2004 Nov. 29(6):676-7. [QxMD MEDLINE Link].
Zaballos P, Ara M, Puig S, Malvehy J. Dermoscopy of sebaceous hyperplasia. Arch Dermatol. 2005 Jun. 141(6):808. [QxMD MEDLINE Link].
Oztas P, Polat M, Oztas M, Alli N, Ustun H. Bonbon toffee sign: a new dermatoscopic feature for sebaceous hyperplasia. J Eur Acad Dermatol Venereol. 2008 Nov. 22(10):1200-2. [QxMD MEDLINE Link].
Alexiades-Armenakas M. Laser-mediated photodynamic therapy. Clin Dermatol. 2006 Jan-Feb. 24(1):16-25. [QxMD MEDLINE Link].
Horio T, Horio O, Miyauchi-Hashimoto H, Ohnuki M, Isei T. Photodynamic therapy of sebaceous hyperplasia with topical 5-aminolaevulinic acid and slide projector. Br J Dermatol. 2003 Jun. 148(6):1274-6. [QxMD MEDLINE Link].
Bader RS, Scarborough DA. Surgical pearl: intralesional electrodesiccation of sebaceous hyperplasia. J Am Acad Dermatol. 2000 Jan. 42(1 Pt 1):127-8. [QxMD MEDLINE Link].
Rosian R, Goslen JB, Brodell RT. The treatment of benign sebaceous hyperplasia with the topical application of bichloracetic acid. J Dermatol Surg Oncol. 1991 Nov. 17(11):876-9. [QxMD MEDLINE Link].
Aghassi D, Gonzalez E, Anderson RR, Rajadhyaksha M, Gonzalez S. Elucidating the pulsed-dye laser treatment of sebaceous hyperplasia in vivo with real-time confocal scanning laser microscopy. J Am Acad Dermatol. 2000 Jul. 43(1 Pt 1):49-53. [QxMD MEDLINE Link].
Walther T, Hohenleutner U, Landthaler M. [Sebaceous gland hyperplasia as a side effect of cyclosporin A. Treatment with the CO2 laser]. Dtsch Med Wochenschr. 1998 Jun 19. 123(25-26):798-800. [QxMD MEDLINE Link].
Liu YS, Cheng YP, Liu CI, Yang CY, Yang CY. Presenile diffuse familial sebaceous hyperplasia successfully treated with low-dose isotretinoin: A report of two cases and review of the published work. J Dermatol. 2016 Oct. 43 (10):1205-1208. [QxMD MEDLINE Link].
Yu C, Shahsavari M, Stevens G, Liskanich R, Horowitz D. Isotretinoin as monotherapy for sebaceous hyperplasia. J Drugs Dermatol. 2010 Jun. 9(6):699-701. [QxMD MEDLINE Link].

Media Gallery

Normal sebaceous gland histology. Courtesy of Cooper Heard, MD.
Histology of sebaceous hyperplasia; enlarged sebaceous gland with multiple lobules grouped around a central dilated sebaceous duct. Courtesy of Cooper Heard, MD.
Typical distribution of sebaceous hyperplasia on the forehead in a middle-aged male.
Close-up of typical sebaceous hyperplasia on the face (red arrows).
Juxtaclavicular beaded lines, a variant of sebaceous hyperplasia, in an elderly man.
Close-up of facial sebaceous hyperplasia.

of 6

Author

David T Robles, MD, PhD, FAAD Dermatologist, Oak Tree Dermatology

David T Robles, MD, PhD, FAAD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Coauthor(s)

Kristin Mickelson, PA-C Dermatology Physician Assistant, Chaparral Medical Group

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Steven R Feldman, MD, PhD Professor, Departments of Dermatology, Pathology and Public Health Sciences, and Molecular Medicine and Translational Science, Wake Forest Baptist Health; Director, Center for Dermatology Research, Director of Industry Relations, Department of Dermatology, Wake Forest University School of Medicine

Steven R Feldman, MD, PhD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, North Carolina Medical Society, Society for Investigative Dermatology

Disclosure: Received honoraria from Amgen for consulting; Received honoraria from Abbvie for consulting; Received honoraria from Galderma for speaking and teaching; Received consulting fee from Lilly for consulting; Received ownership interest from www.DrScore.com for management position; Received ownership interest from Causa Reseasrch for management position; Received grant/research funds from Janssen for consulting; Received honoraria from Pfizer for speaking and teaching; Received consulting fee from No.

Chief Editor

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology, Society for Investigative Dermatology

Disclosure: Received income in an amount equal to or greater than $250 from: Elsevier; WebMD<br/>Served as a speaker for various universities, dermatology societies, and dermatology departments.

Additional Contributors

Daniel J Hogan, MD Clinical Professor of Internal Medicine (Dermatology), Nova Southeastern University College of Osteopathic Medicine; Investigator, Hill Top Research, Florida Research Center

Daniel J Hogan, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Contact Dermatitis Society, Canadian Dermatology Association

Disclosure: Nothing to disclose.

Stephen H Mason, MD

Stephen H Mason, MD is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery, Women's Dermatologic Society, Skin Cancer Foundation

Disclosure: Nothing to disclose.

Arash Taheri, MD Research Fellow, Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine

Disclosure: Nothing to disclose.

Acknowledgements

R Walker Jones, MD Harris M Blackman, MD, LLC

R Walker Jones, MD is a member of the following medical societies: American Chemical Society, American Medical Association, American Medical Student Association/Foundation, and Louisiana State Medical Society

Disclosure: Nothing to disclose.

Sebaceous Hyperplasia Questions & Answers

References

Tables

Contributor Information and Disclosures

What would you like to print?